MedPath
HSA Approval

BONJELA GEL

SIN04303P

BONJELA GEL

BONJELA GEL

April 23, 1990

RECKITT BENCKISER (SINGAPORE) PTE LTD

RECKITT BENCKISER (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantRECKITT BENCKISER (SINGAPORE) PTE LTD
Licence HolderRECKITT BENCKISER (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

GEL

SUBMUCOSAL

Medical Information

A01AD11

various

Manufacturer Information

RECKITT BENCKISER (SINGAPORE) PTE LTD

RECKITT BENCKISER HEALTHCARE (UK) LTD

Active Ingredients

CETALKONIUM CHLORIDE

0.01% w/w

Cetalkonium

CHOLINE SALICYLATE

8.714% W/W

Choline salicylate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BONJELA GEL - HSA Approval | MedPath